Trials / Completed
CompletedNCT00992472
Bioavailability of Prochlorperazine Suppositories, 25 mg
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (planned)
- Sponsor
- Padagis LLC · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare prochlorperazine plasma concentrations produced after administration of the test formulation with those produced after administration of a marketed reference product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prochlorperazine suppositories, 25mg | |
| DRUG | Compazine® suppositories, 25mg |
Timeline
- First posted
- 2009-10-09
- Last updated
- 2021-10-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00992472. Inclusion in this directory is not an endorsement.